C4 Therapeutics to Join September Investor Conferences
C4 Therapeutics, Inc. (C4T) (NASDAQ: CCCC), a clinical-stage biopharmaceutical company focused on advancing the science of targeted protein degradation, has announced its participation in fireside chats at two upcoming investor conferences in September.
Details of the Fireside Chats
The first event is the Wells Fargo Healthcare Conference, which will be held in Boston. C4T management is scheduled to speak on September 5, 2024, at 8:45 AM ET.
The second event is the 2024 Cantor Global Healthcare Conference in New York, where C4T will present on September 18, 2024, at 8:35 AM ET.
Investors can tune in to live webcasts available in the Investors section of the company’s website. Additionally, archived replays will be accessible for around 30 days after the live events.
About C4 Therapeutics
C4 Therapeutics (C4T) (NASDAQ: CCCC) is an innovative clinical-stage biopharmaceutical company dedicated to creating next-generation medicines through the groundbreaking field of targeted protein degradation science. The company’s mission is to advance oncology programs through various clinical trials while improving patient outcomes by addressing difficult-to-treat diseases.
Utilizing its proprietary TORPEDO platform, C4T enhances the design and optimization of small-molecule therapeutics, offering significant promise for patients facing challenging health conditions. These novel degrader medicines effectively engage the body’s natural protein recycling system to eliminate proteins that cause disease, potentially overcoming challenges related to drug resistance and targeting previously considered undruggable proteins.
Dedication to Healthcare Innovation
The efforts at C4 Therapeutics are vital in the ever-evolving biopharmaceutical landscape, especially given the urgent need for new therapies that can succeed where conventional treatments may fall short. This dedication is evident in the ongoing clinical trials and research initiatives aimed at delivering transformative outcomes for patients.
Contact Information for the Company
For any inquiries regarding C4 Therapeutics, interested individuals can reach out to the investor relations team. Courtney Solberg, Senior Manager of Investor Relations, is available at CSolberg@c4therapeutics.com. For media inquiries, Loraine Spreen, Senior Director of Corporate Communications & Patient Advocacy, can be contacted at LSpreen@c4therapeutics.com.
Frequently Asked Questions
What is the purpose of C4 Therapeutics' participation in the conferences?
The purpose is to engage with investors and highlight advancements in targeted protein degradation science and developments at the clinical stage.
When is the Wells Fargo Healthcare Conference?
The Wells Fargo Healthcare Conference is set for September 5, 2024, at 8:45 AM ET.
Where can I find more information about C4 Therapeutics?
You can find more information on the company’s website, which will also host webcasts of the investor engagements.
What is the significance of targeted protein degradation?
Targeted protein degradation is a revolutionary approach that focuses on degrading disease-causing proteins, potentially opening new treatment options for patients, especially those with cancers.
Who can I contact for investor relations at C4 Therapeutics?
Courtney Solberg, Senior Manager of Investor Relations, is the contact person for any investor-related inquiries.